Developing safe and effective drugs for children has long been a challenge for drug developers. With the need to cater to a wide range of ages and sizes, pediatric drug development requires precise and innovative approaches. Our infographic highlights the transformative role of pharmacokinetic (PK) and pharmacodynamic (PD) modeling and simulation in overcoming these challenges.
The infographic covers:
- Leveraging Adult Clinical Trial Data
- Modeling and Simulation of Adult Data for Pediatric Use
- Predicting Successful Doses in Pediatric Patients
Our expertise with pediatric populations includes:
- PopPK/PD modeling
- Clinical trial simulations
- PK/PD extrapolation and allometric scaling
- PBPK to address enzyme maturation
- Pediatric Study/Investigation Plans
Discover how we leverage PK and PD modeling in drug development to improve care for children by exploring our other resources:
- Leveraging PK and PD Modeling in Drug Development
- Enabling Patient-Centric Drug Development
- Fast-Tracking Drug Development
Share This
